CLBT
CLBT
NASDAQ · Technology

Cellebrite Di Ltd

$15.32
-0.32 (-2.05%)
Financial Highlights (FY 2026)
Revenue
468.99M
Net Income
77.22M
Gross Margin
84.2%
Profit Margin
16.5%
Rev Growth
+20.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 84.2% 84.2% 34.9% 34.9%
Operating Margin 14.0% 12.6% 23.1% 21.8%
Profit Margin 16.5% 15.7% 16.9% 18.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 468.99M 388.65M 688.80M 631.53M
Gross Profit 394.89M 327.25M 240.06M 220.10M
Operating Income 65.56M 48.90M 158.95M 137.39M
Net Income 77.22M 57.59M 116.55M 115.17M
Gross Margin 84.2% 84.2% 34.9% 34.9%
Operating Margin 14.0% 12.6% 23.1% 21.8%
Profit Margin 16.5% 15.7% 16.9% 18.2%
Rev Growth +20.7% +20.7% -6.8% +15.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 373.27M 415.63M
Total Equity 2.18B 1.99B
D/E Ratio 0.17 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 77.25M 60.81M 223.67M 228.90M
Free Cash Flow 62.94M 97.33M